Three-drug Regimen for Idiopathic Pulmonary Fibrosis Found HarmfulKansas City infoZineThe trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outco…
Abbott, Biogen report MS drug reduced relapse rate – Boston.com
Abbott, Biogen report MS drug reduced relapse rateBoston.comBiogen Idec and Abbott Laboratories said Sunday a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing rel…
Technology Connects Stroke Experts With Patients in Ozarks – OzarksFirst.com
Technology Connects Stroke Experts With Patients in OzarksOzarksFirst.com"The further you wait the more brain damage, brain death that you can incur," notes Carol Beal, Stroke Program Director at St. John's Regional Health System. "T…
Blood Donation Levels Decline in Detroit, Red Cross Struggling for New Donations – ThirdAge
ThirdAgeBlood Donation Levels Decline in Detroit, Red Cross Struggling for New DonationsThirdAgeBlood donations in the Detroit area are down by about three percent, The Detroit News reports. The decline came at a time when contributions were expected t…
Stocks to watch Monday: Mattel, Biogen Idec – MarketWatch
Stocks to watch Monday: Mattel, Biogen IdecMarketWatchMore good news for Biogen Idec Inc.: The company and Abbott Laboratories Inc. /quotes/zigman/216393/quotes/nls/abt ABT -0.76% on Saturday presented positive data from a trial to evaluate an investig…
A look at the hype behind Omega-3s – SILive.com
A look at the hype behind Omega-3sSILive.com… colon cancer, ulcerative colitis, Crohn's Disease, IgA nephropathy, psoriasis, eczema, asthma, preeclampsia, schizophrenia, bipolar disorder, depression, dysmennorhea, cystic fibrosis, diabetes, hyper…
Biogen jumps on strong MS drug data: Sanofi's Lemtrada significant improvement … – The Pharma Letter
Biogen jumps on strong MS drug data: Sanofi's Lemtrada significant improvement …The Pharma LetterBiogen and partner Abbott Laboratories (NYSE: ABT) also announced additional results from the SELECT Phase IIb trial, the first of two registrational…
Toddler close to being brain-dead: doctors – AsiaOne
AsiaOneToddler close to being brain-dead: doctorsAsiaOne"Her situation somewhat meets the standard of brain death," said Wang Weimin with the General Hospital of the Guangzhou Military Command of the People's Liberation Army. "We can…
Huge boost for The Citizen's organ donor campaign as 8000 sign up – Thisisgloucestershire
Huge boost for The Citizen's organ donor campaign as 8000 sign upThisisgloucestershireMORE than 8000 people have signed up to be potential lifesavers after the launch of an organ donor campaign by The Citizen. People across the county have responde…
OHSU surgeon makes cancer breakthrough – KOIN Local 6
OHSU surgeon makes cancer breakthroughKOIN Local 6The drug is called everolimus. The brand name is AFINITOR. The trial results were amazing, stopping the cancer in its tracks in most cases, and even shrinking it in others. "We just got FDA approva…